FIELD: veterinary medicine.
SUBSTANCE: method involves using virulent strain of viral hemorrhagic disease in rabbits isolated from the regional epizootic focus. The strain is cultured by infection of rabbits non-vaccinated against viral hemorrhagic disease. Liver suspension in the concentration 10-15% is prepared from perished rabbits, raw is inactivated with theotropine as measured 1 g of the preparation per 1000 ml and kept at 37 C for 48 h followed by addition of 1-2% of aluminum potassium sulfate alum, dispensed and corked. Vaccine shows high immunogenicity and harmlessness.
EFFECT: improved preparing, valuable properties of vaccine.
2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| VACCINE AGAINST VIRAL HEMORRHAGIC DISEASE IN RABBITS | 2002 |
|
RU2229895C1 |
| METHOD TO MANUFACTURE VACCINE ASSOCIATED AGAINST STREPTOCOCCOSIS AND VIRUS HAEMORRHAGIC DISEASE OF RABBITS | 2010 |
|
RU2429880C1 |
| METHOD OF MANUFACTURING VACCINE, ASSOCIATED AGAINST PSEUDOMONOSIS AND VIRAL RABBIT HAEMORRHAGIC DISEASE | 2013 |
|
RU2553557C2 |
| METHOD FOR PRODUCING ASSOCIATED COLIBACILLOSIS, STREPTOCOCCOSIS AND RABBIT VIRAL HEMORRHAGIC DISEASE VACCINE | 2010 |
|
RU2443774C1 |
| METHOD FOR PRODUCING ASSOCIATED SALMONELLOSIS, ESCHERICHIOSIS AND RABBIT VIRAL HEMORRHAGIC DISEASE VACCINE | 2012 |
|
RU2496518C1 |
| ASSOCIATED STREPTOCOCCOSIS AND RABBIT VIRAL HEMORRHAGIC DISEASE VACCINE | 2010 |
|
RU2429879C1 |
| ASSOCIATED SALMONELLOSIS, ESCHERICHIOSIS AND RABBIT VIRAL HAEMORRHAGIC DISEASE VACCINE | 2012 |
|
RU2510839C2 |
| ASSOCIATED COLIBACILLOSIS, STREPTOCOCCOSIS AND RABBIT VIRAL HEMORRHAGIC DISEASE VACCINE | 2010 |
|
RU2443775C1 |
| ASSOCIATED PSEUDOMONOSIS AND RABBIT VIRAL HAEMORRHAGIC DISEASE VACCINE | 2013 |
|
RU2531054C1 |
| STRAIN "SHEVCHENKO-2014" OF RABBIT HEMORRHAGIC DISEASE VIRUS FOR PREPARING VACCINES, DIAGNOSTIC AND THERAPEUTIC PREPARATIONS | 2015 |
|
RU2631925C2 |
